The announcement on the 19/07/2023 said
Pharmacokinetic Results – Potential for R327 to be Used to Treat Sepsis
The results showed a significant dose-dependent concentration of R327 in both the urine and the
plasma, highlighting the potential of R327 as a potential treatment of sepsis and
complicated/uncomplicated UTIs.
Ann: Positive Phase II Data from Clinical Trial of R327 Gel, page-93
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
0.010(3.33%) |
Mkt cap ! $89.39M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 31.5¢ | 31.0¢ | $1.865K | 6.015K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6135 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 18753 | 3 |
View Market Depth
| Last trade - 10.47am 27/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |